DEDD (death effector domain containing) is a multifunctional scaffold protein with primary roles in apoptosis regulation and transcriptional control. As a death effector domain-containing protein, DEDD associates with caspase-8 and caspase-10 to mediate death receptor-induced apoptosis, with nuclear localization playing a key role in its pro-apoptotic function 1. DEDD translocates to the nucleolus following CD95 signaling where it inhibits RNA polymerase I-dependent transcription 2. Additionally, DEDD forms nuclear complexes with TFIIIC102, a subunit of transcription factor IIIC, functioning as a regulator of general transcription machinery 3. Beyond apoptosis, DEDD acts as a tumor suppressor through novel mechanisms: it interacts with PI3KC3 to activate autophagy and degrade EMT master regulators Snail and Twist, attenuating epithelial-mesenchymal transition in breast cancer 4. DEDD expression is inversely correlated with poor prognosis in breast and colon cancers 4. Clinically, DEDD expression levels predict chemotherapy sensitivity and Bcl-2 inhibitor responsiveness; low DEDD correlates with chemoresistance and enhanced sensitivity to ABT-199 5. In urothelial carcinoma, DEDD amplification promotes aggressive disease progression 6. Recent evidence demonstrates DEDD mediates ZIPK-induced neuronal apoptosis in traumatic brain injury via caspase-3 activation 7, suggesting DEDD inhibition as a therapeutic strategy for neuroprotection.